{"organizations": [], "uuid": "c12842a4c5f3be7c90617db79355cb1d63b55ea0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "uk.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/UKhealth/", "section_title": "Reuters: Health News", "url": "https://uk.reuters.com/article/us-inogen-stocks/inogens-shares-drop-on-short-seller-citrons-tweet-idUKKCN1IP2I7", "country": "US", "domain_rank": 408, "title": "Inogen's shares drop on short seller Citron's tweet", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-24T17:42:00.000+03:00", "replies_count": 0, "uuid": "c12842a4c5f3be7c90617db79355cb1d63b55ea0"}, "author": "", "url": "https://uk.reuters.com/article/us-inogen-stocks/inogens-shares-drop-on-short-seller-citrons-tweet-idUKKCN1IP2I7", "ord_in_thread": 0, "title": "Inogen's shares drop on short seller Citron's tweet", "locations": [], "entities": {"persons": [{"name": "inogen", "sentiment": "negative"}, {"name": "citron", "sentiment": "negative"}, {"name": "vibhuti sharma", "sentiment": "none"}, {"name": "bernard orr", "sentiment": "none"}], "locations": [{"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "inogen", "sentiment": "negative"}, {"name": "inogen inc", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "citron research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 24, 2018 / 2:45 PM / Updated 40 minutes ago Inogen's shares drop on short seller Citron's tweet Reuters Staff 1 Min Read\n(Reuters) - Shares of Inogen Inc fell nearly 7 percent on Thursday after short seller Citron Research called the oxygen supply device maker the most expensive name in medical technology with no pipeline.\nShares of the company were trading down at $161.88. Reporting by Vibhuti Sharma in Bengaluru; Editing by Bernard Orr", "external_links": [], "published": "2018-05-24T17:42:00.000+03:00", "crawled": "2018-05-24T18:27:37.000+03:00", "highlightTitle": ""}